Exosomes from adipose-derived mesenchymal stem cell improve diabetic wound healing and inhibit fibrosis via miR-128-1-5p/TGF-β1/Smad axis
Molecular and Cellular Endocrinology · 2024-07 · 588 · 112213
DOI: 10.1016/j.mce.2024.112213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024-07. Verfasst von Qiu Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China; Anhui Key Laborator…. Hauptthemen laut MEDLINE: MicroRNAs, Wound Healing, Transforming Growth Factor beta1, Fibrosis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Bengbu Medical University.
Themen: Wundversorgung
Abstract (Originalsprache)
OBJECTIVE: Difficult-to-heal wound is a prevalent and significant complication of diabetes, characterized by impaired functionality of epithelial cells such as fibroblasts. This study aims to investigate the potential mechanism of ADSC-Exos promoting diabetic wound healing by regulating fibroblast function. MATERIALS AND METHODS: ADSC-Exos were confirmed through TEM, NTA, and Western Blot techniques. The study conducted on rat skin fibroblasts (RSFs) exposed to 33 mmol/L glucose in vitro. We used cck-8, EDU, transwell, and scratch assays to verify the proliferation and migration of RSFs. Furthermore, levels of TGF-β1 and α-SMA proteins were determined by immunofluorescence and Western Blot. RSFs were transfected with miR-128-1-5p mimics and inhibitors, followed by quantification of TGF-β1, α-SMA, Col I and Smad2/3 protein levels using Western Blot. In vivo, the effects of ADSC-Exos on diabetic wounds were assessed using digital imaging, histological staining, as well as Western Blot analysis. RESULTS: In vitro, ADSC-Exos significantly enhanced proliferation and migration of RSFs while reducing the expression of TGF-β1 and α-SMA. In vivo, ADSC-Exos effectively promoted diabetic wound healing and mitigated scar fibrosis. Additionally, ADSC-Exos exhibited elevated levels of miR-128-1-5p, which targets TGF-β1, resulting in a notable reduction in TGF-β1, α-SMA, Col I and smad2/3 phosphorylation in RSFs. CONCLUSION: In conclusion, our results demonstrated that ADSC-Exos promoted diabetic wound healing, and inhibited skin fibrosis by regulating miR-128-1-5p/TGF-β1/Smad signaling pathway, which provides a promising innovative treatment for diabetic wound healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China; Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical University, Bengbu, Anhui,…
- Department of Plastic Surgery and Burn, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China.
- Department of Prevention and Health Care, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, 233000, China. Electronic address: ShenYan2330@163.com.
Förderung
- Bengbu Medical University
Zitieren
APA
Liang, Q., Zhou, D., Ge, X., Song, P., Chu, W., Xu, J., & Shen, Y. (2024). Exosomes from adipose-derived mesenchymal stem cell improve diabetic wound healing and inhibit fibrosis via miR-128-1-5p/TGF-β1/Smad axis. Molecular and Cellular Endocrinology, 588, 112213. https://doi.org/10.1016/j.mce.2024.112213
Vancouver
Liang Q, Zhou D, Ge X, Song P, Chu W, Xu J, et al. Exosomes from adipose-derived mesenchymal stem cell improve diabetic wound healing and inhibit fibrosis via miR-128-1-5p/TGF-β1/Smad axis. Molecular and Cellular Endocrinology. 2024;588:112213. doi:10.1016/j.mce.2024.112213
BibTeX
@article{Liang2024,
author = {Liang, Qiu and Zhou, Danlian and Ge, Xiuyu and Song, Peijun and Chu, Weiwei and Xu, Jing and Shen, Yan},
title = {Exosomes from adipose-derived mesenchymal stem cell improve diabetic wound healing and inhibit fibrosis via miR-128-1-5p/TGF-β1/Smad axis},
journal = {Molecular and Cellular Endocrinology},
year = {2024},
volume = {588},
pages = {112213},
doi = {10.1016/j.mce.2024.112213}
}
EUVIMED